Company Search:
Advanced Search
Sponsored Links
Pain Therapeutics, Inc. Company Snapshot
Pain Therapeutics, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pain Therapeutics with three other companies in this sector in the United States: ImmunoGen, Inc. (2013 sales of $35.54 million of which 100% was Cancer Therapeutics), Alnylam Pharmaceuticals, Inc. ($47.17 million of which 100% was Research Collaborator), and Xoma Corporation ($35.45 million of which 100% was Biopharmaceutical Pro).

Sales Analysis. Sales increased substantially in 2013: During the year ended December of 2013, sales at Pain Therapeutics were $41.12 million. This is an increase of 277.6% versus 2012, when the company's sales were $10.89 million.
  Stock Performance Chart for Pain Therapeutics, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 7.79
(Figures in U.S. Dollars)
1 Week -0.1%   13 Weeks 84.2%  
4 Weeks 103.1%   52 Weeks 92.2%  
Pain Therapeutics, Inc. Key Data:
  Ticker: PTIE Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2013 Sales 41,119,000
(Year Ending Jan 2014).
Employees: 9
  Currency: U.S. Dollars Market Cap: 51,379,015
  Fiscal Yr Ends: December Shares Outstanding: 6,595,509
  Share Type: Common Closely Held Shares: 207,206
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.